Published: 31 Mar 2022 | Report Code: 10248432 | Pages: 193
Global bioanalytical testing services market will reach $7,902.9 million by 2031, growing by 9.1% annually over 2021-2031, driven by the rising demand for analytical testing of biologics and biosimilars amid COVID-19 pandemic, increasing preference for outsourcing analytical testing, growing R&D expenditure in the pharmaceutical and biopharmaceutical industries, and the rising adoption of the Quality by Design (QbD) approach. Highlighted with 88 tables and 111 figures, this 193-page report “Global Bioanalytical Testing Services Market 2021-2031 by Molecule Type (Small, Large), Application (Bioavailability and Bioequivalence, PK, PD, ADME), Test Type (Cell-based, Virology, SINA, MDOV, Biomarker), Workflow Process (Sample Preparation, Sample Analysis, Others), Therapeutic Area (Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology), End User (Pharma and Biopharma Companies, CDMOs, CROs), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global bioanalytical testing services market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global bioanalytical testing services market in every aspect of the classification from perspectives of Molecule Type, Application, Test Type, Workflow Process, Therapeutic Area, End User, and Region. Based on Molecule Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Small Molecules • Large Molecules o LC-MS Studies o Immunoassays o Other Large Molecule Tests Based Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Bioavailability and Bioequivalence Studies • Pharmacokinetics (PK) • Pharmacodynamics (PD) • Absorption, Distribution, Metabolism, Excretion (ADME) • Other Applications By Test Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Cell-based Assays o Bacterial Cell-based Assays o Viral Cell-based Assays • Virology Testing o In Vitro Virology Testing o In Vivo Virology Testing o Species-Specific Viral PCR Assays • Serology, Immunogenicity, and Neutralizing Antibodies (SINA) o Bacterial Serology, Immunogenicity, and Neutralizing Antibodies o Viral Serology, Immunogenicity, and Neutralizing Antibodies • Method Development Optimization and Validation (MDOV) • Biomarker Testing • Pharmacokinetic Testing • Other Test Types By Workflow Process, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Sample Preparation o Protein Precipitation o Liquid-liquid Extraction (LLE) • Sample Analysis o Hyphenated Technique o Chromatographic Technique o Electrophoresis o Ligand Binding Assay o Mass Spectrometry o Nuclear Magnetic Resonance • Other Workflow Processes By Therapeutic Area, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Oncology • Neurology • Infectious Diseases • Gastroenterology • Cardiology • Other Therapeutic Areas By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Pharma and Biopharma Companies • Contract Development and Manufacturing Organizations (CDMOs) • Contract Research Organizations (CROs) Geographically, the following regions together with the listed national/local markets are fully investigated: • North America (U.S., Canada, and Mexico) • Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) • South America (Brazil, Chile, Argentina, Rest of South America) • MEA (UAE, Saudi Arabia, South Africa, Other Nations) For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of key national markets by Application, Workflow Process, and Therapeutic Area over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Charles River Laboratories International Inc. Covance Inc. Eurofins Scientific ICON PLC Intertek Group PLC IQVIA Holdings, Inc. Laboratory Corporation of America Holdings Medpace Holdings, Inc. Pace Analytical Services LLC. Parexel International Corporation PPD Inc. SGS SA Syneos Health, LLC Toxikon Corporation WuXi Apptech Co., Ltd. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Table Of Contents:
11 1.1 Industry Definition and Research Scope 11 1.1.1 Industry Definition 11 1.1.2 Research Scope 12 1.2 Research Methodology 15 1.2.1 Overview of Market Research Methodology 15 1.2.2 Market Assumption 16 1.2.3 Secondary Data 16 1.2.4 Primary Data 16 1.2.5 Data Filtration and Model Design 17 1.2.6 Market Size/Share Estimation 18 1.2.7 Research Limitations 19 1.3 Executive Summary 20 2 Market Overview and Dynamics 23 2.1 Market Size and Forecast 23 2.1.1 Impact of COVID-19 on World Economy 24 2.1.2 Impact of COVID-19 on the Market 26 2.2 Major Growth Drivers 31 2.3 Market Restraints and Challenges 34 2.4 Emerging Opportunities and Market Trends 37 2.5 Porter’s Fiver Forces Analysis 41 3 Segmentation of Global Market by Molecule Type 45 3.1 Market Overview by Molecule Type 45 3.2 Small Molecules 47 3.3 Large Molecules 48 3.3.1 LC-MS Studies 49 3.3.2 Immunoassays 50 3.3.3 Other Large Molecule Tests 51 4 Segmentation of Global Market by Application 52 4.1 Market Overview by Application 52 4.2 Bioavailability and Bioequivalence Studies 54 4.3 Pharmacokinetics (PK) 55 4.4 Pharmacodynamics (PD) 56 4.5 Absorption, Distribution, Metabolism, Excretion (ADME) 57 4.6 Other Applications 58 5 Segmentation of Global Market by Test Type 59 5.1 Market Overview by Test Type 59 5.2 Cell-based Assays 61 5.2.1 Bacterial Cell-based Assays 62 5.2.2 Viral Cell-based Assays 63 5.3 Virology Testing 64 5.3.1 In Vitro Virology Testing 65 5.3.2 In Vivo Virology Testing 66 5.3.3 Species-Specific Viral PCR Assays 67 5.4 Serology, Immunogenicity, and Neutralizing Antibodies (SINA) 68 5.4.1 Bacterial Serology, Immunogenicity, and Neutralizing Antibodies 69 5.4.2 Viral Serology, Immunogenicity, and Neutralizing Antibodies 70 5.5 Method Development Optimization and Validation (MDOV) 71 5.6 Biomarker Testing 72 5.7 Pharmacokinetic Testing 73 5.8 Other Test Types 74 6 Segmentation of Global Market by Workflow Process 75 6.1 Market Overview by Workflow Process 75 6.2 Sample Preparation 77 6.2.1 Protein Precipitation 78 6.2.2 Liquid-liquid Extraction (LLE) 79 6.2.3 Solid Phase Extraction (SPE) 80 6.3 Sample Analysis 81 6.3.1 Hyphenated Technique 83 6.3.2 Chromatographic Technique 84 6.3.3 Electrophoresis 85 6.3.4 Ligand Binding Assay 86 6.3.5 Mass Spectrometry 87 6.3.6 Nuclear Magnetic Resonance 88 6.4 Other Workflow Processes 89 7 Segmentation of Global Market by Therapeutic Area 90 7.1 Market Overview by Therapeutic Area 90 7.2 Oncology 92 7.3 Neurology 93 7.4 Infectious Diseases 94 7.5 Gastroenterology 95 7.6 Cardiology 96 7.7 Other Therapeutic Areas 97 8 Segmentation of Global Market by End User 98 8.1 Market Overview by End User 98 8.2 Pharma and Biopharma Companies 100 8.3 Contract Development and Manufacturing Organizations (CDMOs) 101 8.4 Contract Research Organizations (CROs) 102 9 Segmentation of Global Market by Region 103 9.1 Geographic Market Overview 2021-2031 103 9.2 North America Market 2021-2031 by Country 107 9.2.1 Overview of North America Market 107 9.2.2 U.S. 111 9.2.3 Canada 114 9.2.4 Mexico 116 9.3 European Market 2021-2031 by Country 118 9.3.1 Overview of European Market 118 9.3.2 Germany 122 9.3.3 U.K. 124 9.3.4 France 126 9.3.5 Spain 128 9.3.6 Italy 130 9.3.7 Russia 132 9.3.8 Rest of European Market 134 9.4 Asia-Pacific Market 2021-2031 by Country 136 9.4.1 Overview of Asia-Pacific Market 136 9.4.2 Japan 140 9.4.3 China 143 9.4.4 Australia 145 9.4.5 India 147 9.4.6 South Korea 149 9.4.7 Rest of APAC Region 151 9.5 South America Market 2021-2031 by Country 153 9.5.1 Argentina 156 9.5.2 Brazil 158 9.5.3 Chile 160 9.5.4 Rest of South America Market 162 9.6 MEA Market 2021-2031 by Country 163 9.6.1 UAE 166 9.6.2 Saudi Arabia 168 9.6.3 South Africa 170 9.6.4 Other National Markets 172 10 Competitive Landscape 173 10.1 Overview of Key Vendors 173 10.2 New Product Launch, Partnership, Investment, and M&A 176 10.3 Company Profiles 177 Charles River Laboratories International Inc. 177 Covance Inc. 179 Eurofins Scientific 180 ICON PLC 181 Intertek Group PLC 182 IQVIA Holdings, Inc. 183 Laboratory Corporation of America Holdings 184 Medpace Holdings, Inc. 185 Pace Analytical Services LLC. 186 Parexel International Corporation 187 PPD Inc. 188 SGS SA 189 Syneos Health, LLC 190 Toxikon Corporation 191 WuXi Apptech Co., Ltd. 192 RELATED REPORTS 193
List Of Tables:
Table 1. Snapshot of Global Bioanalytical Testing Services Market in Balanced Perspective, 2021-2031 21 Table 2. World Economic Outlook, 2021-2031 25 Table 3. World Health Spending by Region, $ bn, 2013-2020 30 Table 4. Main Product Trends and Market Opportunities in Global Bioanalytical Testing Services Market 37 Table 5. Global Bioanalytical Testing Services Market by Molecule Type, 2021-2031, $ mn 45 Table 6. Global Bioanalytical Testing Services Market: Large Molecules Testing by Technology, 2021-2031, $ mn 48 Table 7. Global Bioanalytical Testing Services Market by Application, 2021-2031, $ mn 52 Table 8. Global Bioanalytical Testing Services Market by Test Type, 2021-2031, $ mn 59 Table 9. Global Bioanalytical Testing Services Market: Cell-based Assays by Type, 2021-2031, $ mn 61 Table 10. Global Bioanalytical Testing Services Market: Virology Testing by Type, 2021-2031, $ mn 64 Table 11. Global Bioanalytical Testing Services Market: Serology, Immunogenicity, and Neutralizing Antibodies (SINA) by Type, 2021-2031, $ mn 68 Table 12. Global Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn 75 Table 13. Global Bioanalytical Testing Services Market: Sample Preparation by Method, 2021-2031, $ mn 77 Table 14. Global Bioanalytical Testing Services Market: Sample Analysis by Technology, 2021-2031, $ mn 82 Table 15. Global Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn 90 Table 16. Global Bioanalytical Testing Services Market by End User, 2021-2031, $ mn 98 Table 17. Global Bioanalytical Testing Services Market by Region, 2021-2031, $ mn 104 Table 18. Leading National Bioanalytical Testing Services Market, 2021 and 2031, $ mn 106 Table 19. North America Bioanalytical Testing Services Market by Country, 2021-2031, $ mn 109 Table 20. U.S. Bioanalytical Testing Services Market by Application, 2021-2031, $ mn 113 Table 21. U.S. Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn 113 Table 22. U.S. Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn 113 Table 23. Canada Bioanalytical Testing Services Market by Application, 2021-2031, $ mn 115 Table 24. Canada Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn 115 Table 25. Canada Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn 115 Table 26. Mexico Bioanalytical Testing Services Market by Application, 2021-2031, $ mn 117 Table 27. Mexico Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn 117 Table 28. Mexico Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn 117 Table 29. Europe Bioanalytical Testing Services Market by Country, 2021-2031, $ mn 121 Table 30. Germany Bioanalytical Testing Services Market by Application, 2021-2031, $ mn 123 Table 31. Germany Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn 123 Table 32. Germany Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn 123 Table 33. U.K. Bioanalytical Testing Services Market by Application, 2021-2031, $ mn 125 Table 34. U.K. Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn 125 Table 35. U.K. Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn 125 Table 36. France Bioanalytical Testing Services Market by Application, 2021-2031, $ mn 127 Table 37. France Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn 127 Table 38. France Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn 127 Table 39. Spain Bioanalytical Testing Services Market by Application, 2021-2031, $ mn 129 Table 40. Spain Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn 129 Table 41. Spain Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn 129 Table 42. Italy Bioanalytical Testing Services Market by Application, 2021-2031, $ mn 131 Table 43. Italy Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn 131 Table 44. Italy Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn 131 Table 45. Russia Bioanalytical Testing Services Market by Application, 2021-2031, $ mn 133 Table 46. Russia Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn 133 Table 47. Russia Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn 133 Table 48. Bioanalytical Testing Services Market in Rest of Europe by Country, 2021-2031, $ mn 135 Table 49. APAC Bioanalytical Testing Services Market by Country, 2021-2031, $ mn 138 Table 50. Japan Bioanalytical Testing Services Market by Application, 2021-2031, $ mn 142 Table 51. Japan Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn 142 Table 52. Japan Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn 142 Table 53. China Bioanalytical Testing Services Market by Application, 2021-2031, $ mn 144 Table 54. China Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn 144 Table 55. China Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn 144 Table 56. Australia Bioanalytical Testing Services Market by Application, 2021-2031, $ mn 146 Table 57. Australia Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn 146 Table 58. Australia Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn 146 Table 59. India Bioanalytical Testing Services Market by Application, 2021-2031, $ mn 148 Table 60. India Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn 148 Table 61. India Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn 148 Table 62. South Korea Bioanalytical Testing Services Market by Application, 2021-2031, $ mn 150 Table 63. South Korea Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn 150 Table 64. South Korea Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn 150 Table 65. Bioanalytical Testing Services Market in Rest of APAC by Country/Region, 2021-2031, $ mn 152 Table 66. South America Bioanalytical Testing Services Market by Country, 2021-2031, $ mn 155 Table 67. Argentina Bioanalytical Testing Services Market by Application, 2021-2031, $ mn 157 Table 68. Argentina Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn 157 Table 69. Argentina Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn 157 Table 70. Brazil Bioanalytical Testing Services Market by Application, 2021-2031, $ mn 159 Table 71. Brazil Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn 159 Table 72. Brazil Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn 159 Table 73. Chile Bioanalytical Testing Services Market by Application, 2021-2031, $ mn 161 Table 74. Chile Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn 161 Table 75. Chile Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn 161 Table 76. MEA Bioanalytical Testing Services Market by Country, 2021-2031, $ mn 165 Table 77. UAE Bioanalytical Testing Services Market by Application, 2021-2031, $ mn 167 Table 78. UAE Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn 167 Table 79. UAE Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn 167 Table 80. Saudi Arabia Bioanalytical Testing Services Market by Application, 2021-2031, $ mn 169 Table 81. Saudi Arabia Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn 169 Table 82. Saudi Arabia Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn 169 Table 83. South Africa Bioanalytical Testing Services Market by Application, 2021-2031, $ mn 171 Table 84. South Africa Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn 171 Table 85. South Africa Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn 171 Table 86. Charles River Laboratories International Inc.: Company Snapshot 177 Table 87. Charles River Laboratories International Inc.: Business Segmentation 178 Table 88. Charles River Laboratories International Inc.: Product Portfolio 178
List Of Figures:
Figure 1. Research Method Flow Chart 15 Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 18 Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 20 Figure 4. Global Bioanalytical Testing Services Market, 2021-2031, $ mn 23 Figure 5. Impact of COVID-19 on Business 26 Figure 6. Leading Causes of Death in the World, 2019-2020, million 28 Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 29 Figure 8. World Population 65 and Over, % of Total Population, 1950-2060 29 Figure 9. Primary Drivers and Impact Factors of Global Bioanalytical Testing Services Market 31 Figure 10. Primary Restraints and Impact Factors of Global Bioanalytical Testing Services Market 34 Figure 11. Investment Opportunity Analysis 38 Figure 12. Porter’s Fiver Forces Analysis of Global Bioanalytical Testing Services Market 41 Figure 13. Breakdown of Global Bioanalytical Testing Services Market by Molecule Type, 2021-2031, % of Revenue 46 Figure 14. Global Addressable Market Cap in 2022-2031 by Molecule Type, Value ($ mn) and Share (%) 46 Figure 15. Global Bioanalytical Testing Services Market by Molecule Type: Small Molecules, 2021-2031, $ mn 47 Figure 16. Global Bioanalytical Testing Services Market by Molecule Type: Large Molecules, 2021-2031, $ mn 48 Figure 17. Global Bioanalytical Testing Services Market by Large Molecules: LC-MS Studies, 2021-2031, $ mn 49 Figure 18. Global Bioanalytical Testing Services Market by Large Molecules: Immunoassays, 2021-2031, $ mn 50 Figure 19. Global Bioanalytical Testing Services Market by Large Molecules: Other Large Molecule Tests, 2021-2031, $ mn 51 Figure 20. Breakdown of Global Bioanalytical Testing Services Market by Application, 2021-2031, % of Sales Revenue 53 Figure 21. Global Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%) 53 Figure 22. Global Bioanalytical Testing Services Market by Application: Bioavailability and Bioequivalence Studies, 2021-2031, $ mn 54 Figure 23. Global Bioanalytical Testing Services Market by Application: Pharmacokinetics (PK), 2021-2031, $ mn 55 Figure 24. Global Bioanalytical Testing Services Market by Application: Pharmacodynamics (PD), 2021-2031, $ mn 56 Figure 25. Global Bioanalytical Testing Services Market by Application: Absorption, Distribution, Metabolism, Excretion (ADME), 2021-2031, $ mn 57 Figure 26. Global Bioanalytical Testing Services Market by Application: Other Applications, 2021-2031, $ mn 58 Figure 27. Breakdown of Global Bioanalytical Testing Services Market by Test Type, 2021-2031, % of Sales Revenue 60 Figure 28. Global Addressable Market Cap in 2022-2031 by Test Type, Value ($ mn) and Share (%) 60 Figure 29. Global Bioanalytical Testing Services Market by Test Type: Cell-based Assays, 2021-2031, $ mn 61 Figure 30. Global Bioanalytical Testing Services Market by Cell-based Assays: Bacterial Cell-based Assays, 2021-2031, $ mn 62 Figure 31. Global Bioanalytical Testing Services Market by Cell-based Assays: Viral Cell-based Assays, 2021-2031, $ mn 63 Figure 32. Global Bioanalytical Testing Services Market by Test Type: Virology Testing, 2021-2031, $ mn 64 Figure 33. Global Bioanalytical Testing Services Market by Virology Testing: In Vitro Virology Testing, 2021-2031, $ mn 65 Figure 34. Global Bioanalytical Testing Services Market by Virology Testing: In Vivo Virology Testing, 2021-2031, $ mn 66 Figure 35. Global Bioanalytical Testing Services Market by Virology Testing: Species-Specific Viral PCR Assays, 2021-2031, $ mn 67 Figure 36. Global Bioanalytical Testing Services Market by Test Type: Serology, Immunogenicity, and Neutralizing Antibodies (SINA), 2021-2031, $ mn 68 Figure 37. Global Bioanalytical Testing Services Market by Serology, Immunogenicity, and Neutralizing Antibodies (SINA): Bacterial Serology, Immunogenicity, and Neutralizing Antibodies, 2021-2031, $ mn 69 Figure 38. Global Bioanalytical Testing Services Market by Serology, Immunogenicity, and Neutralizing Antibodies (SINA): Viral Serology, Immunogenicity, and Neutralizing Antibodies, 2021-2031, $ mn 70 Figure 39. Global Bioanalytical Testing Services Market by Test Type: Method Development Optimization and Validation (MDOV), 2021-2031, $ mn 71 Figure 40. Global Bioanalytical Testing Services Market by Test Type: Biomarker Testing, 2021-2031, $ mn 72 Figure 41. Global Bioanalytical Testing Services Market by Test Type: Pharmacokinetic Testing, 2021-2031, $ mn 73 Figure 42. Global Bioanalytical Testing Services Market by Test Type: Other Test Types, 2021-2031, $ mn 74 Figure 43. Breakdown of Global Bioanalytical Testing Services Market by Workflow Process, 2021-2031, % of Revenue 76 Figure 44. Global Addressable Market Cap in 2022-2031 by Workflow Process, Value ($ mn) and Share (%) 76 Figure 45. Global Bioanalytical Testing Services Market by Workflow Process: Sample Preparation, 2021-2031, $ mn 77 Figure 46. Global Bioanalytical Testing Services Market by Sample Preparation: Protein Precipitation, 2021-2031, $ mn 78 Figure 47. Global Bioanalytical Testing Services Market by Sample Preparation: Liquid-liquid Extraction (LLE), 2021-2031, $ mn 79 Figure 48. Global Bioanalytical Testing Services Market by Sample Preparation: Solid Phase Extraction (SPE), 2021-2031, $ mn 80 Figure 49. Global Bioanalytical Testing Services Market by Workflow Process: Sample Analysis, 2021-2031, $ mn 81 Figure 50. Global Bioanalytical Testing Services Market by Sample Analysis: Hyphenated Technique, 2021-2031, $ mn 83 Figure 51. Global Bioanalytical Testing Services Market by Sample Analysis: Chromatographic Technique, 2021-2031, $ mn 84 Figure 52. Global Bioanalytical Testing Services Market by Sample Analysis: Electrophoresis, 2021-2031, $ mn 85 Figure 53. Global Bioanalytical Testing Services Market by Sample Analysis: Ligand Binding Assay, 2021-2031, $ mn 86 Figure 54. Global Bioanalytical Testing Services Market by Sample Analysis: Mass Spectrometry, 2021-2031, $ mn 87 Figure 55. Global Bioanalytical Testing Services Market by Sample Analysis: Nuclear Magnetic Resonance, 2021-2031, $ mn 88 Figure 56. Global Bioanalytical Testing Services Market by Workflow Process: Other Workflow Processes, 2021-2031, $ mn 89 Figure 57. Breakdown of Global Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, % of Revenue 91 Figure 58. Global Addressable Market Cap in 2022-2031 by Therapeutic Area, Value ($ mn) and Share (%) 91 Figure 59. Global Bioanalytical Testing Services Market by Therapeutic Area: Oncology, 2021-2031, $ mn 92 Figure 60. Global Bioanalytical Testing Services Market by Therapeutic Area: Neurology, 2021-2031, $ mn 93 Figure 61. Global Bioanalytical Testing Services Market by Therapeutic Area: Infectious Diseases, 2021-2031, $ mn 94 Figure 62. Global Bioanalytical Testing Services Market by Therapeutic Area: Gastroenterology, 2021-2031, $ mn 95 Figure 63. Global Bioanalytical Testing Services Market by Therapeutic Area: Cardiology, 2021-2031, $ mn 96 Figure 64. Global Bioanalytical Testing Services Market by Therapeutic Area: Other Therapeutic Areas, 2021-2031, $ mn 97 Figure 65. Breakdown of Global Bioanalytical Testing Services Market by End User, 2021-2031, % of Revenue 98 Figure 66. Global Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 99 Figure 67. Global Bioanalytical Testing Services Market by End User: Pharma and Biopharma Companies, 2021-2031, $ mn 100 Figure 68. Global Bioanalytical Testing Services Market by End User: Contract Development and Manufacturing Organizations (CDMOs), 2021-2031, $ mn 101 Figure 69. Global Bioanalytical Testing Services Market by End User: Contract Research Organizations (CROs), 2021-2031, $ mn 102 Figure 70. Global Market Snapshot by Region 103 Figure 71. Geographic Spread of Worldwide Bioanalytical Testing Services Market, 2021-2031, % of Sales Revenue 104 Figure 72. Global Addressable Market Cap in 2022-2031 by Region, Value ($ mn) and Share (%) 105 Figure 73. North American Bioanalytical Testing Services Market, 2021-2031, $ mn 108 Figure 74. Breakdown of North America Bioanalytical Testing Services Market by Country, 2021 and 2031, % of Revenue 109 Figure 75. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 110 Figure 76. U.S. Bioanalytical Testing Services Market, 2021-2031, $ mn 112 Figure 77. Canada Bioanalytical Testing Services Market, 2021-2031, $ mn 114 Figure 78. Bioanalytical Testing Services Market in Mexico, 2021-2031, $ mn 116 Figure 79. European Bioanalytical Testing Services Market, 2021-2031, $ mn 119 Figure 80. Breakdown of European Bioanalytical Testing Services Market by Country, 2021 and 2031, % of Revenue 120 Figure 81. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 121 Figure 82. Bioanalytical Testing Services Market in Germany, 2021-2031, $ mn 122 Figure 83. Bioanalytical Testing Services Market in U.K., 2021-2031, $ mn 124 Figure 84. Bioanalytical Testing Services Market in France, 2021-2031, $ mn 126 Figure 85. Bioanalytical Testing Services Market in Spain, 2021-2031, $ mn 128 Figure 86. Bioanalytical Testing Services Market in Italy, 2021-2031, $ mn 130 Figure 87. Bioanalytical Testing Services Market in Russia, 2021-2031, $ mn 132 Figure 88. Bioanalytical Testing Services Market in Rest of Europe, 2021-2031, $ mn 134 Figure 89. Asia-Pacific Bioanalytical Testing Services Market, 2021-2031, $ mn 137 Figure 90. Breakdown of APAC Bioanalytical Testing Services Market by Country, 2021 and 2031, % of Revenue 137 Figure 91. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 139 Figure 92. Bioanalytical Testing Services Market in Japan, 2021-2031, $ mn 141 Figure 93. Bioanalytical Testing Services Market in China, 2021-2031, $ mn 143 Figure 94. Bioanalytical Testing Services Market in Australia, 2021-2031, $ mn 145 Figure 95. Bioanalytical Testing Services Market in India, 2021-2031, $ mn 147 Figure 96. Bioanalytical Testing Services Market in South Korea, 2021-2031, $ mn 149 Figure 97. Bioanalytical Testing Services Market in Rest of APAC, 2021-2031, $ mn 151 Figure 98. South America Bioanalytical Testing Services Market, 2021-2031, $ mn 154 Figure 99. Breakdown of South America Bioanalytical Testing Services Market by Country, 2021 and 2031, % of Revenue 154 Figure 100. Contribution to South America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 155 Figure 101. Bioanalytical Testing Services Market in Argentina, 2021-2031, $ mn 156 Figure 102. Bioanalytical Testing Services Market in Brazil, 2021-2031, $ mn 158 Figure 103. Bioanalytical Testing Services Market in Chile, 2021-2031, $ mn 160 Figure 104. Bioanalytical Testing Services Market in Rest of South America, 2021-2031, $ mn 162 Figure 105. Bioanalytical Testing Services Market in Middle East and Africa (MEA), 2021-2031, $ mn 164 Figure 106. Breakdown of MEA Bioanalytical Testing Services Market by Country, 2021 and 2031, % of Revenue 164 Figure 107. Contribution to MEA 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 165 Figure 108. Bioanalytical Testing Services Market in UAE, 2021-2031, $ mn 166 Figure 109. Bioanalytical Testing Services Market in Saudi Arabia, 2021-2031, $ mn 168 Figure 110. Bioanalytical Testing Services Market in South Africa, 2021-2031, $ mn 170 Figure 111. Growth Stage of Global Bioanalytical Testing Services Industry over the Forecast Period 173
Selected Key Players: Charles River Laboratories International Inc. Covance Inc. Eurofins Scientific ICON PLC Intertek Group PLC IQVIA Holdings, Inc. Laboratory Corporation of America Holdings Medpace Holdings, Inc. Pace Analytical Services LLC. Parexel International Corporation PPD Inc. SGS SA Syneos Health, LLC Toxikon Corporation WuXi Apptech Co., Ltd. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)